ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 52 filers reported holding ADC THERAPEUTICS SA in Q4 2020. The put-call ratio across all filers is 5.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,176,000 | -39.4% | 451,637 | -0.0% | 0.00% | -33.3% |
| Q2 2022 | $3,592,000 | -42.0% | 451,827 | +7.2% | 0.00% | -25.0% |
| Q1 2022 | $6,189,000 | -27.3% | 421,297 | +0.0% | 0.00% | -20.0% |
| Q4 2021 | $8,508,000 | -17.5% | 421,174 | +10.9% | 0.01% | -28.6% |
| Q3 2021 | $10,314,000 | +11.5% | 379,748 | -0.1% | 0.01% | +16.7% |
| Q2 2021 | $9,254,000 | -0.0% | 380,049 | +0.2% | 0.01% | -14.3% |
| Q1 2021 | $9,255,000 | -15.0% | 379,137 | +11.5% | 0.01% | -12.5% |
| Q4 2020 | $10,886,000 | +24.5% | 340,089 | +28.3% | 0.01% | 0.0% |
| Q3 2020 | $8,747,000 | – | 265,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
| Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
| Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
| MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
| Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
| HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
| Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
| CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
| Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |